3.8 Article

The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model

Journal

JOURNAL OF OPHTHALMIC & VISION RESEARCH
Volume 18, Issue 1, Pages 68-80

Publisher

KNOWLEDGE E
DOI: 10.18502/jovr.v18i1.12727

Keywords

Chemotherapy; Intravitreal; Nanoparticles; Ocular Malignancy; Retinoblastoma; Topotecan

Categories

Ask authors/readers for more resources

This study aimed to evaluate the efficacy of thiolated chitosan-dextran nanoparticles (TPH-CMD-TCS-NPs) in improving intravitreal chemotherapy of retinoblastoma in a rabbit xenograft model. The results showed that the NPs had a mean diameter of 30 +/- 4 nm, a polydispersity index of 0.24 +/- 0.03, and a zeta potential of +10 +/- 3 mV. The TPH-CMD-TCS-NPs group showed a significant decrease in tumor volume compared to the control group (P = 0.039).
Purpose: This research intended to fabricate the thiolated chitosan-dextran nanoparticles (NPs) containing topotecan (TPH-CMD-TCS-NPs) to assess the ability of NPs in improving the efficacy of intravitreal chemotherapy of retinoblastoma in a rabbit xenograft model. Methods: The coacervation process was used to produce the NPs. The cellular uptake of Cyanine-3 (CY3)-labeled NPs were investigated in human retinoblastoma Y79 cells using confocal microscopy. Also, the prepared TPH-CMD-TCS-NPs were tested in vitro by the tetrazolium dyes II (XTT) and flow cytometry in order to assess their cytotoxicity. In addition, a rabbit xenograft model of retinoblastoma was developed to test the antitumor effectiveness of TPH-CMD-TCS-NPs through intravitreal administration. Results: NPs had a mean diameter, polydispersity index, and zeta potential of 30 +/- 4 nm, 0.24 +/- 0.03 and +10 +/- 3 mV, respectively. NPs (IC50s 40.40 compared to 126.20 nM, P = 0.022) were more effective than free topotecan as a dose-based feature. The tumor reaction to intravitreal chemotherapy with NPs was measured by evaluating the percentage of necrosis in the tumor tissue (91 +/- 2%) and vitreous seeds (89 +/- 9%) through hematoxylin and eosin (H&E) staining. In comparison with the control group, the TPH-CMD-TCs-NPs treated group showed a significant decrease in tumor volume seven days after the intravitreal injection (P = 0.039). No significant changes were found in the ERG parameters after the intravitreal injection of TPH-CMD-TCs-NPs or TPH (P > 0.05). Conclusion: This investigation revealed definitive antitumor efficacy of TPH-CMD-TCS-NPs by intravitreal administration in the rabbit xenograft retinoblastoma model.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available